Bilfinger supports construction of Boehringer vaccine plant

The equipment, tailored to Boehringer’s specific customer requirements, includes 34 virus culture and downstream processing tanks as well as ready-to-use modules called skids

Bilfinger has supplied production equipment for a large-scale animal vaccine facility for Boehringer Ingelheim in Lyon-Jonage, France. The €17.5m ($2.05m) order includes the design, prefabrication, construction, installation and commissioning of process equipment for the upstream and downstream processing of the vaccine production.

“With this contract for Boehringer Ingelheim, Bilfinger continues on its growth path in the biopharma industry,” said Christina Johansson, Interim CEO and CFO of Bilfinger. “By offering state-of-the-art design, fabrication and commissioning of essential process equipment from one single source, we provide bespoke solutions as well as an efficient project execution to our long-standing customer.”

The equipment, tailored to Boehringer’s specific customer requirements, includes 34 virus culture and downstream processing tanks as well as ready-to-use modules called skids.

With the majority of all on-site installation activities already completed, the Bilfinger team is now finalizing the mechanical completion and commissioning of the equipment for major process steps of the vaccine manufacturing procedure: the upstream processing, in which virus cells are cultivated, and the downstream processing, in which the antigen is harvested and purified.

The company also complies with hygiene and safety regulations to ensure product quality.

Companies